UnknownNot Applicable

Stellate Ganglion Destruction With Alcohol Versus Thermal Ablation for Chronic Post Mastectomy Pain

Egypt70 participantsStarted 2023-01-01

Plain-language summary

* Group A: SGB with alcohol injection by ultrasound guidance and C7 level confirmation by fluoroscopy. * Group B: Thermal RF; thermal RF neurolysis will be applied with a time of 60 seconds at 80º C, and then will be repeated twice . Stellate ganglion RF therapy will be done under fluoroscopy, integrated by ultrasound guidance

Who can participate

Age range

20 Years – 65 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female patient 20-65yrs underwent surgery for breast cancer * Pain duration of more than 6 months * Pain is moderate to severe pain (visual analog scale \[VAS\] ≥ 4 cm), * Pain described as a refractory one that is defined as pain for which classic biomedical therapy has proven ineffective * Pain is of positive neuropathic character as detected by the grading system for neuropathic pain (GSNP), with a score of 3 or 4 Exclusion Criteria: * Refusal of the patient * Recent myocardial infarction * Anti-coagulated patients or coagulopathy (evaluate risk/benefit ratio) * Glaucoma * Pre-existing counter lateral nerve palsy * Severe emphysema * Cardiac conduction block * Local and systemic sepsis * Local anatomical distortion (which may render the block technically difficult or hazardous. * Psychiatric illness.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Changes in VAS

Timeframe: 12 WEEKS

Trial details

NCT IDNCT05771103

SponsorNational Cancer Institute, Egypt

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-07-30

Contact for this trial

suzan adlan, lecturer

01111068300 dr_s.adlan@hotmail.com

View on ClinicalTrials.gov More Post-mastectomy Pain Syndrome trials